Comment on: drug prices were not a "Wolf" 
 
 

The 2015-06-17 13:50:29 | source: southern daily 

    Drug prices, we also should pay attention to how to unified planning and comprehensive treatment, medicine, medical expenses and management from the system and mechanism system. 
 
    Since June 1st, the national development and reform commission and other departments cancelled most of the drugs government pricing, drug actual transaction prices are mainly formed by the market competition. This is our country for the first time in nearly 20 years aggressively to abolish the file and measures to control prices. Unexpectedly, the New Deal implementation of 10 days, however, has the media to expose a variety of drug prices. Over the years, the hospital in a state of "deformity" medicine for the medical, we heard the "price" 2 words, people were conditioned reflex, exclaim, "Wolf", believe that only a price drop down again, we see a doctor expensive problem can be solved. But in fact we are vigilant drug "capricious" price increases at the same time, also learned that the drug prices too low is not good, we need to know, to see the doctor take reasonable drug prices aren't the only ones this link works, and the improvement of the health care system, and so on several factors. 
 
    Once upon a time, in the media, everyone in the collective memory of some classic cheap drugs, because controlled the drug price is low, drug companies give up production, a variety of drugs once shortage. Cheap commonly used medicines treating first overbearing disease, for example -- a sulfhydryl imidazole, once the "shortage of medicine", in the country has caused the wide attention of the society. Domestic methyl sulfhydryl imidazole piece due to the low price (nt $100 for 1-2 for before) is the first choice for patients with hyperthyroidism, but the drug profit space is little, drug firms less incentive to produce. From the end of 2012, a sulfhydryl imidazole have break goods across the country, and a sulfhydryl imidazole suffer the same fate, and protamine. In the middle of September, 2011, the shortage of protamine event successively in Shanghai, the size of the hospital surgery, the doctor ran to borrow overnight. A sulfhydryl imidazole and protamine experience of the two drugs, it is in recent years, many cheap medicine "common destiny". When cheap to no profit or even lose money, waiting for it is the fate of the automatic shutdown or changed. According to the statistics, has disappeared under five yuan cheap drugs, nearly thirty percent of the commonly used cheap medicine. 
 
    Cheap drugs because the market price is lower than the cost, the enterprise choose retreat city is a moral bottom line. Remember a few years ago, has a "generic drug king," said the sichuan shu pharmaceutical suspected of fraud, made with apple peel, radix isatidis, in order to reduce costs. By the state food and drug administration found that the proprietary Chinese medicine production line were ordered to stop production. Before the problems exposed, the pharmaceutical producing drugs in shu basic price is like this: 8 cents a ageratum water of vital qi, 1 cents a pack of banlangen granule, 6 yuan a bottle of the effect. Cheap is cheap, but you dare to buy? 
 
    After the pricing reform, these "cheap" medicines will be made by production operators according to the production cost and market supply and demand situation of independent pricing, this gives a lot of cheap drugs production created the policy space. Good medicine for classic back into the market, price increases are inevitable, drug price also is not the "Wolf". Voucher only in terms of drug price cut, it is difficult to avoid drug costs lower and check the rising cost of treatment, patients eventually pay the total cost with a doctor, isn't there will be a fundamental change. Drug prices, we also should pay attention to how to unified planning and comprehensive treatment, medicine, medical expenses and management from the system and mechanism system. 
 
    As the medicine price, director of the institute of China pharmaceutical university Chang Feng on the matter about it: "the drug cost burden of the masses not only depends on the drug prices, still depends on the structure and health security level. On the basis of rational drug prices, through strengthening regulation of medical practice, realize the reasonable medical treatment (including the rational use of drugs), improving the structure of the drug, effectively reduce the drug expense. At the same time, the medical insurance fund can combine the capacity of the masses, improve the level of security appropriate for reasonable price rise of drugs, can guarantee basic does not increase the burden of the masses."
 
 
 
Li jieren